Bill Information > HB 2565
Search for another bill or initiative:
HB 2565 - 2017-18
Concerning drug and gene therapy payment for medicaid managed care organizations.
2018 REGULAR SESSION
First reading, referred to Health Care & Wellness (Not Officially read and referred until adoption of Introduction report). (View Original Bill)
Public hearing in the House Committee on Health Care & Wellness at 8:00 AM. (Committee Materials)
Executive session scheduled, but no action was taken in the House Committee on Health Care & Wellness at 1:30 PM. (Committee Materials)
Executive action taken in the House Committee on Health Care & Wellness at 8:00 AM. (Committee Materials)
Referred to Rules 2 Review.
Placed on second reading by Rules Committee.
1st substitute bill substituted (HCW 18). (View 1st Substitute)
Floor amendment(s) adopted.
Rules suspended. Placed on Third Reading.
IN THE SENATE
First reading, referred to Health & Long Term Care.
By resolution, returned to House Rules Committee for third reading.
For a complete list of documents, go to Online Reports Text of a Legislative Document.